Brand-specific incremental lifetime cancer risk subtotals: \batchmode \documentclass[fleqn,10pt,legalpaper]{article} \usepackage{amssymb} \usepackage{amsfonts} \usepackage{amsmath} \pagestyle{empty} \begin{document} \(\mathrm{ILCR}^{\mathrm{sub}{\Sigma}}_{1... Brand-specific incremental lifetime cancer risk subtotals: \batchmode \documentclass[fleqn,10pt,legalpaper]{article} \usepackage{amssymb} \usepackage{amsfonts} \usepackage{amsmath} \pagestyle{empty} \begin{document} \(\mathrm{ILCR}^{\mathrm{sub}{\Sigma}}_{1}\) \end{document} (all cancer end points) and \batchmode \documentclass[fleqn,10pt,legalpaper]{article} \usepackage{amssymb} \usepackage{amsfonts} \usepackage{amsmath} \pagestyle{empty} \begin{document} \(\mathrm{ILCR}^{\mathrm{sub{\Sigma}{-}lung}}_{1}\) \end{document} (known human lung carcinogens only) for both CSF sets I and II. The average values \batchmode \documentclass[fleqn,10pt,legalpaper]{article} \usepackage{amssymb} \usepackage{amsfonts} \usepackage{amsmath} \pagestyle{empty} \begin{document} \(\overline{\mathrm{ILCR}}^{\mathrm{sub{\Sigma}}}_{1}\) \end{document} and \batchmode \documentclass[fleqn,10pt,legalpaper]{article} \usepackage{amssymb} \usepackage{amsfonts} \usepackage{amsmath} \pagestyle{empty} \begin{document} \(\overline{\mathrm{ILCR}}^{\mathrm{sub{\Sigma}{-}lung}}_{1}\) \end{document} are marked. James F. Pankow et al. Cancer Epidemiol Biomarkers Prev 2007;16:584-592 ©2007 by American Association for Cancer Research